These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2384917)
41. Induction of antibodies to the bluetongue virus core polypeptide VP7 in sheep by internal image rabbit antiidiotypic antibodies. Lin M; Zhou EM; Heckert RA Viral Immunol; 1996; 9(1):35-43. PubMed ID: 8733918 [TBL] [Abstract][Full Text] [Related]
42. Identification of subgroups of bovine respiratory syncytial virus. Baker JC; Wilson EG; McKay GL; Stanek RJ; Underwood WJ; Velicer LF; Mufson MA J Clin Microbiol; 1992 May; 30(5):1120-6. PubMed ID: 1583108 [TBL] [Abstract][Full Text] [Related]
47. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination]. Pothier P Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219 [No Abstract] [Full Text] [Related]
48. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein. García J; García-Barreno B; Martinez I; Melero JA Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311 [TBL] [Abstract][Full Text] [Related]
49. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies. Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550 [TBL] [Abstract][Full Text] [Related]
50. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies. Sullender WM; Edwards KG Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149 [TBL] [Abstract][Full Text] [Related]
51. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. Anderson LJ; Hierholzer JC; Tsou C; Hendry RM; Fernie BF; Stone Y; McIntosh K J Infect Dis; 1985 Apr; 151(4):626-33. PubMed ID: 2579169 [TBL] [Abstract][Full Text] [Related]
53. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583 [TBL] [Abstract][Full Text] [Related]
54. The production of monoclonal antibodies against respiratory syncytial virus and its clinical applications. Wu B Clin Lab Med; 1985 Sep; 5(3):589-613. PubMed ID: 3899483 [TBL] [Abstract][Full Text] [Related]
55. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein. Martínez I; Melero JA J Gen Virol; 1998 Sep; 79 ( Pt 9)():2215-20. PubMed ID: 9747731 [TBL] [Abstract][Full Text] [Related]
56. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein. Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562 [TBL] [Abstract][Full Text] [Related]
57. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Murphy BR; Sotnikov AV; Lawrence LA; Banks SM; Prince GA Vaccine; 1990 Oct; 8(5):497-502. PubMed ID: 2251875 [TBL] [Abstract][Full Text] [Related]
58. Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities. Hendry RM; Fernie BF; Anderson LJ; Godfrey E; McIntosh K J Immunol Methods; 1985 Mar; 77(2):247-58. PubMed ID: 3981003 [TBL] [Abstract][Full Text] [Related]
59. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals. Hariharan K; Nara PL; Caralli VM; Norton FL; Haigwood N; Kang CY J Virol; 1993 Feb; 67(2):953-60. PubMed ID: 7678311 [TBL] [Abstract][Full Text] [Related]
60. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein. Trudel M; Nadon F; Séguin C; Binz H Virology; 1991 Dec; 185(2):749-57. PubMed ID: 1720589 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]